Curis (CRIS) Change in Cash (2010 - 2026)
Curis' (CRIS) quarterly Change in Cash came in at $9.9 million in Q1 2026, up 3387.72% YoY from $285000.0 in Q1 2025, and up 349.12% on a QoQ basis from -$4.0 million in Q4 2025.
Curis (CRIS) Change in Cash (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Change in Cash data on file, last reported at $9.9 million in Q1 2026.
- Quarterly Change in Cash rose 3387.72% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.3 million (up 45.41% YoY) and the FY2025 annual result came in at -$14.9 million, down 123.46% from the prior year.
- Change in Cash improved to $9.9 million in Q1 2026, from -$4.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $15.4 million in Q2 2022 to a low of -$21.5 million in Q1 2022.
- A 5-year average of -$1.5 million and a median of -$857000.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash slumped 365.58% — and 2026, when it surged 3387.72%.
- Tracing CRIS's Change in Cash over 5 years: stood at -$10.2 million in 2022, then soared by 121.71% to $2.2 million in 2023, then plunged by 138.73% to -$857000.0 in 2024, then tumbled by 365.58% to -$4.0 million in 2025, then jumped by 349.12% to $9.9 million in 2026.
- The last three Change in Cash figures came in at $9.9 million (Q1 2026), -$4.0 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - | -9.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.94 Mn |
| Dec 31, 2025 | -3.99 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -10.14 Mn |
| Mar 31, 2025 | 285,000.00 |
| Dec 31, 2024 | -857,000.00 |
| Sep 30, 2024 | 10.86 Mn |
| Jun 30, 2024 | -19.96 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 4.56 Mn |
| Jun 30, 2023 | -11.87 Mn |
| Mar 31, 2023 | 12.04 Mn |
| Dec 31, 2022 | -10.19 Mn |
| Sep 30, 2022 | -4.16 Mn |
| Jun 30, 2022 | 15.45 Mn |
| Mar 31, 2022 | -21.55 Mn |
| Dec 31, 2021 | -13.01 Mn |
| Sep 30, 2021 | -22.10 Mn |
| Jun 30, 2021 | -36.01 Mn |